Based on 3,897 Wall Street analysts offering 12 month price targets to DE:ISQ1 holdings in the last 3 months. The average price target is €322.98 with a high forecast of €418.34 and a low forecast of €238.90. The average price target represents a 47.92% change from the last price of €218.35.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"176":"€176","419":"€419","236.75":"€236.8","297.5":"€297.5","358.25":"€358.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":418.337,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€418.34</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":322.977,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€322.98</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":238.903,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€238.90</span>\n  </div></div>","useHTML":true}}],"tickPositions":[176,236.75,297.5,358.25,419],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Apr<br/>2024","6":"Jul<br/>2024","9":"Oct<br/>2024","12":"Jan<br/>2025","25":"Jan<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n              \n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,213.45,229.21053846153845,244.9710769230769,260.7316153846154,276.4921538461538,292.2526923076923,308.01323076923074,323.77376923076923,339.53430769230766,355.29484615384615,371.0553846153846,386.81592307692307,402.57646153846156,{"y":418.337,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,213.45,221.87515384615384,230.30030769230768,238.72546153846153,247.15061538461538,255.57576923076923,264.0009230769231,272.4260769230769,280.85123076923077,289.2763846153846,297.70153846153846,306.1266923076923,314.5518461538461,{"y":322.977,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,213.45,215.40792307692305,217.36584615384615,219.32376923076922,221.2816923076923,223.23961538461538,225.19753846153844,227.15546153846154,229.1133846153846,231.0713076923077,233.02923076923076,234.98715384615383,236.94507692307693,{"y":238.903,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":178.854,"date":1704153600000,"info":"<div>Price: <b>€179<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":177.965,"date":1706745600000,"info":"<div>Price: <b>€178<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":186.365,"date":1709251200000,"info":"<div>Price: <b>€186<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":191.883,"date":1712016000000,"info":"<div>Price: <b>€192<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":182.292,"date":1714608000000,"info":"<div>Price: <b>€182<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":189.208,"date":1717372800000,"info":"<div>Price: <b>€189<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":187.736,"date":1719792000000,"info":"<div>Price: <b>€188<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":202.154,"date":1722470400000,"info":"<div>Price: <b>€202<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":197.037,"date":1725235200000,"info":"<div>Price: <b>€197<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":196.93,"date":1727740800000,"info":"<div>Price: <b>€197<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":198.785,"date":1730419200000,"info":"<div>Price: <b>€199<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":228.516,"date":1733097600000,"info":"<div>Price: <b>€229<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":213.45,"date":1735776000000,"info":"<div>Price: <b>€213<b/></div>","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€418.34

Average Price Target€322.98

Lowest Price Target€238.90

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

ISQ1 Stocks With Highest Upside Potential

xxxxxxxxxxxxxxxxxxxxxxxxxxx

IVVD

Invivyd

3 Buy

0 Hold

0 Sell

Strong Buy

$7.52

xxxxxxxxxxxxxxxxxxxxxxxxxxx

TNYA

Tenaya Therapeutics, Inc.

8 Buy

0 Hold

0 Sell

Strong Buy

$22.00

xxxxxxxxxxxxxxxxxxxxxxxxxxx

INZY

Inozyme Pharma, Inc.

8 Buy

0 Hold

0 Sell

Strong Buy

$19.00

xxxxxxxxxxxxxxxxxxxxxxxxxxx

JSPR

Jasper Therapeutics, Inc.

10 Buy

0 Hold

0 Sell

Strong Buy

$62.78

xxxxxxxxxxxxxxxxxxxxxxxxxxx

ELEV

Elevation Oncology, Inc.

6 Buy

0 Hold

0 Sell

Strong Buy

$8.00

ISQ1 Stocks With Highest Downside Potential

No stocks with downside potential were found for this ETF

Please check back later or explore other ETFs for potential investment opportunities.

ISQ1 ETF FAQ

What is DE:ISQ1’s average 12-month price target, according to analysts?

Based on analyst ratings, DE:ISQ1’s 12-month average price target is €322.98.

What is DE:ISQ1’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for DE:ISQ1, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is DE:ISQ1 a Buy, Sell or Hold?

Currently, no data Available

What is DE:ISQ1’s price target?

The average price target for DE:ISQ1 is €322.98. This is based on 3897 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is €418.34 ,the lowest forecast is €238.90. The average price target represents N/A Increase from the current price of N/A.

What do analysts say about DE:ISQ1?

Not enough analysts have published a price target to provide an average price target.

How can I buy shares of DE:ISQ1?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing